Abstract

Body size is an important modifiable risk factor for postmenopausal breast cancer. However, it remains unclear whether direct measures of fat mass are better indicators of risk than anthropometric measures, or whether central adiposity may contribute to risk beyond overall adiposity. We analyzed data from 162,691 postmenopausal women in UK Biobank followed from 2006 to 2014. Body size was measured by trained technicians. Multivariable‐adjusted Cox regression was used to estimate relative risks. Analyses were stratified by age at recruitment, region and socioeconomic status, and adjusted for family history of breast cancer, age at menarche, age at first birth, parity, age at menopause, previous hormone replacement therapy use, smoking, alcohol intake, height, physical activity and ethnicity. We observed 2,913 incident invasive breast cancers during a mean 5.7 years of follow‐up. There was a continuous increase in risk of postmenopausal breast cancer with increasing adiposity, across all measures. The point estimate, comparing women in the top (median 37.6 kg) to bottom (median 17.6 kg) quartile of body fat mass was 1.70 (95% confidence interval 1.52–1.90). The magnitudes of the associations between per SD increase in BMI and body fat mass with breast cancer risk were similar, suggesting impedance measures of fat were not substantially better indicators of risk than anthropometric measures. After adjusting for body fat mass, the associations between anthropometric measures of central adiposity and breast cancer risk were attenuated. The magnitude of risk, across all measures of adiposity, was greater in women who had been postmenopausal for 12 or more years.

Highlights

  • There are several important known risk factors for breast cancer, excess adiposity is one of the few modifiable ones

  • The relative risks, comparing the top with the bottom quartiles, were marginally greater for fat mass measured by impedance, but the RRs per standard deviation (SD) increase and v2 statistics associated with each index of adiposity were of similar magnitude

  • All measures of central adiposity were associated with postmenopausal breast cancer risk but these associations were attenuated after adjusting for body fat mass

Read more

Summary

Introduction

There are several important known risk factors for breast cancer, excess adiposity is one of the few modifiable ones. Previous studies have demonstrated an association between obesity and increased risk for postmenopausal breast cancer,[1] but questions remain about this relationship and its underlying mechanisms. Since adipose tissue is the major site. Due to high cost and difficulty of implementation, most large prospective cohort studies have been unable to directly address this question, instead examining the association between obesity and breast cancer risk using only traditional anthropometric measures such as body mass index (BMI), waist circumference and waist-to-hip ratio, which do not directly distinguish between lean and fat mass.[4,5,6,7] While BMI is unable to capture changes in adiposity with age, bioelectrical impedance measures reflect increases in fat mass with age.[8] it is unclear whether the distribution of adipose tissue is relevant for breast cancer risk.[9] Most studies rely on self-reported measures of body size, which tend to underestimate adiposity.[10] We aim here to clarify the association between obesity and postmenopausal breast cancer risk using data on bioelectrical impedance measures of body fat in UK Biobank, a nationwide study of 500,000 individuals

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call